Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat
- PMID: 2392508
- DOI: 10.1007/BF02245736
Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat
Abstract
Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neurons systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.
Similar articles
-
Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis.Brain Res. 1989 Jun 26;490(2):339-44. doi: 10.1016/0006-8993(89)90251-5. Brain Res. 1989. PMID: 2765867
-
Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.Eur J Pharmacol. 1983 Mar 25;88(2-3):195-203. doi: 10.1016/0014-2999(83)90006-7. Eur J Pharmacol. 1983. PMID: 6133769
-
[beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics].Yakubutsu Seishin Kodo. 1989 Dec;9(4):335-48. Yakubutsu Seishin Kodo. 1989. PMID: 2698018 Review. Japanese.
-
Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.Pharmacol Biochem Behav. 1987 Apr;26(4):821-7. doi: 10.1016/0091-3057(87)90616-2. Pharmacol Biochem Behav. 1987. PMID: 2440058
-
2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.Neurochem Res. 1993 Sep;18(9):1015-22. doi: 10.1007/BF00966762. Neurochem Res. 1993. PMID: 7901780 Review.
Cited by
-
Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.Neurochem Int. 2014 Jan;66:27-32. doi: 10.1016/j.neuint.2014.01.006. Epub 2014 Jan 22. Neurochem Int. 2014. PMID: 24462584
-
Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.Brain Res Bull. 2001 Nov 15;56(5):453-62. doi: 10.1016/s0361-9230(01)00613-x. Brain Res Bull. 2001. PMID: 11750790 Free PMC article. Review.
-
β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.Neurochem Int. 2014 Jul;73:27-31. doi: 10.1016/j.neuint.2013.10.010. Epub 2013 Oct 23. Neurochem Int. 2014. PMID: 24161617 Free PMC article.
-
From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency.J Neural Transm (Vienna). 2018 Nov;125(11):1589-1599. doi: 10.1007/s00702-018-1888-y. Epub 2018 May 10. J Neural Transm (Vienna). 2018. PMID: 29748850 Free PMC article. Review.
-
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.Int Rev Neurobiol. 2011;100:13-42. doi: 10.1016/B978-0-12-386467-3.00002-9. Int Rev Neurobiol. 2011. PMID: 21971001 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources